tiprankstipranks
Kairos Pharma, Ltd. (KAPA)
NYSE MKT:KAPA
US Market
Holding KAPA?
Track your performance easily

Kairos Pharma, Ltd. (KAPA) Financial Statements

12 Followers

Kairos Pharma, Ltd. Financial Overview

Kairos Pharma, Ltd.'s market cap is currently ―. The company's EPS TTM is $-0.213; its P/E ratio is -7.50; Kairos Pharma, Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -241.00K$ -307.00K-$ -297.00K-
EBITDA$ -182.00K$ -247.00K-$ -297.00K-
Net Income Common Stockholders$ -253.00K$ -323.00K-$ -312.00K-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 21.00K$ 40.00K$ 93.00K$ 99.00K$ 437.00K
Total Assets$ 1.03M$ 972.00K$ 965.00K$ 948.00K$ 1.04M
Total Debt$ 779.00K$ 657.00K$ 638.00K$ 612.00K$ 582.00K
Net Debt$ 758.00K$ 617.00K$ 545.00K$ 513.00K$ 145.00K
Total Liabilities$ 3.68M$ 3.37M$ 3.04M$ 2.82M$ 2.21M
Stockholders Equity$ -2.65M$ -2.40M$ -2.08M$ -1.87M$ -1.18M
Cash Flow-
Free Cash Flow$ -168.00K$ 36.00K$ 66.00K--
Operating Cash Flow$ -168.00K$ 36.00K$ 66.00K--
Investing Cash Flow-----
Financing Cash Flow$ 149.00K$ -89.00K$ -72.00K--
Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History

Kairos Pharma, Ltd. Debt to Assets

Kairos Pharma, Ltd. Cash Flow

Kairos Pharma, Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis